Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? - Wikidata - awgldk - TriplyDB

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

http://www.wikidata.org/entity/Q30856729

about

Correlation of human epidermal growth factor receptor protein expression and colorectal cancer HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas.HER-2 overexpression and survival in colorectal cancer: a meta-analysis Immunohistochemical results of HER2/neu protein expression assessed by rabbit monoclonal antibodies SP3 and 4B5 in colorectal carcinomas Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivo HER2/neu testing in primary colorectal carcinoma.Significance of human epidermal growth factor receptor 2 expression in colorectal cancer.Expression of COX-2 and HER-2 in colorectal cancer and their correlation.Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series.HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials.Genomic markers of panitumumab resistance including ERBB2/ HER2 in a phase II study of KRAS wild-type (wt) metastatic colorectal cancer (mCRC).The role of personalized medicine in metastatic colorectal cancer: an evolving landscape.The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67 Design and Synthesis of Near-Infrared Peptide for in Vivo Molecular Imaging of HER2 Optical molecular imaging and its emerging role in colorectal cancer.Cell surface markers in colorectal cancer prognosis.Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer.Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.Pertuzumab in gastrointestinal cancer.Role of fumonisin B1 on DNA methylation changes in rat kidney and liver cells.EMMPRIN reduction via scFv-M6-1B9 intrabody affects α3β1-integrin and MCT1 functions and results in suppression of progressive phenotype in the colorectal cancer cell line Caco-2.KRAS, BRAF, EGFR and HER2 gene status in a Spanish population of colorectal cancer.HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer's disease.Up-regulation of Ago2 expression in gastric carcinoma.Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma.The prognostic value of HER-2/neu overexpression in colorectal cancer: evidence from 16 studies.The Importance of VEGF-KDR Signaling Pathway Genes should Not Be Ignored When the Risk of Developing Multiple Sclerosis is Taken into Consideration.Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives

P2860

Q26801167-BF30BB61-A93C-47D3-96E9-AB1A066C11FD Q28078111-CAC12D26-3913-4C9D-A61F-F65A454E8178 Q33690070-A8AB41BF-A667-4A35-BFD0-8ADBA365B31A Q33694931-B615BAF0-2AED-414E-B9F5-92D81CC04551 Q33943812-5FCAB6DC-2364-46C3-83B6-6AEE6C20709D Q33979049-0E05D235-8019-415D-955E-ED69451F9BFC Q34029360-97E4169B-9D91-489F-AE77-F025BCABD711 Q34104079-E44B0CD7-466D-4BDC-BF28-C7782DA8BBE2 Q34499615-08E6ADC4-7837-487F-8951-8495BF515FEA Q34585338-05802EBE-0BB5-469A-A751-5EEFA380BF8B Q35651481-65CE4B9D-1463-448F-856E-08DC2CD3DAB9 Q35957036-2C01CA69-68AD-494F-861A-3BAC751253A0 Q36655951-27F3FDED-E144-45FA-8965-91A0464F4755 Q36671427-39F76410-75BD-4139-AC1C-6001978D4AFD Q37109905-C0F2CC59-3BC7-4E54-A1D3-34C62328F56A Q37130603-AC109A09-54BC-435B-8B25-926FEA52A140 Q37564008-679BB313-C786-4BA0-8FAB-E972460608F4 Q37741398-66D9E553-724F-42F3-950B-C5D6FA40B529 Q37769375-0F7E63E0-61B5-46D6-9919-C010703B498E Q37845669-7E946CB9-2811-4BD0-97AD-B128059D29C8 Q38087507-5FEF6810-5B09-4A52-83EC-ED338D7B562C Q38384113-3AF2BFDD-EB4C-4331-A87A-6901E4F25306 Q38493679-ACE48CED-C201-46DA-BAEB-92BFF9E77304 Q38648453-01489D93-3313-40FA-ABEF-8448B343F11F Q38653309-C7F29921-97EE-4453-9AD7-BBA564F2296F Q38889150-644EA856-6BEE-4EE0-91BE-300A3FA6F3AF Q38985433-615B2FDD-224C-4398-892E-1AD8E9F98DBF Q39861972-F44A0383-08AD-4836-BE81-39B349CA4703 Q43825401-B29625DF-517D-4774-82B8-E758C063FB59 Q48332447-E21B2CEE-B57F-4180-8B1A-E353AAE09AAA Q50899995-4675390E-89C5-4A8A-B01A-A368D6087944 Q53091400-7F729619-832A-41C0-8331-90890BC62EF9 Q54333943-B7C3049D-3EEB-46A8-9ECE-6A97F48D883D Q55001626-95EE5A30-D211-4BCF-9957-B2305E525DF3 Q57739115-830F0470-E14C-44EC-8B81-0CBBD0E5712B

P2860

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

http://www.wikidata.org/entity/Q30856729

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

@ast

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

@en

type

label

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

@ast

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

@en

prefLabel

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

@ast

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

@en

P1433

Q30856729-1DDC6BD1-819B-45B1-AF60-03D8328C9BA5

P1476

Q30856729-AF4D4CAC-56F4-454B-9853-BF06A87CAF04

P2093

Q30856729-0AEBEC3A-A579-4F5C-9543-759303A5710D

Q30856729-374BEA9D-3F0F-4541-973B-25B32969F992

Q30856729-4AAD3ED3-BD0E-444E-8062-858FB9A2203E

Q30856729-7877DE49-BD65-4263-96A9-E823BDF730FD

Q30856729-7E89989D-D6CA-40FE-8D29-601F4013C0E3

Q30856729-ABED3658-2796-4135-9341-20DBE964C920

Q30856729-DE81AA92-3F2B-4B9A-B0E1-FE723EEFADA8

Q30856729-E1F0BEA7-AA67-4D35-A14E-DF469C964B25

P2860

Q30856729-15F64E1C-930D-4861-BF0E-585DAEF35F75

Q30856729-161E833E-7673-4376-B0BB-6B173FB072FA

Q30856729-1829537F-4384-407F-AFAF-C07E3C66477F

Q30856729-1FB5A013-6F33-4E2E-8684-62D6630FC523

Q30856729-2BB7DABC-3688-484E-A18E-3B4CDD4F21DE

Q30856729-37F1ACBD-69E3-49CD-9F33-B166DD0FA8EB

Q30856729-380DB96F-828F-40CB-8037-3BA32B1D841E

Q30856729-412B873E-1824-4B91-A61B-6EE340F681EA

Q30856729-55076160-C9F5-41D1-8777-988E48F2FE8F

Q30856729-76176818-6E7A-4591-A780-CE3B9C8F0278

P2888

Q30856729-157B40C2-60F5-4AB9-9161-28BF75A698C6

P304

Q30856729-FD45E0FF-098A-4A4D-9F52-7738B0AE6C4C

P31

Q30856729-D73DB62E-B04E-4411-BA6C-20FBBFD15EA6

P356

Q30856729-9D59AD4A-5F39-4D8D-B24B-B9F241B54BE0

P407

Q30856729-8E5020B3-6905-4939-9DAF-2130FD908712

P478

Q30856729-297322D6-C3D9-4B10-84EE-5F18F33191C9

P577

Q30856729-505667AC-3D3A-4510-81DF-43CE7AF5A855

P5875

Q30856729-C9C9BD66-AAEE-491A-94E5-1C7B5C4B3397

P6179

Q30856729-2DCF55D4-1E56-4B48-9CC3-3BF9CEFDB90C

P698

Q30856729-F44236DD-307C-48C2-94D7-DBE00555BBF9

P921

Q30856729-7B1B3EAF-FEE7-4567-82DB-55A74DCC551E

Q30856729-D9594650-828B-4876-9328-C0CB6ECC5796

P932

Q30856729-E4AFE354-EF05-4936-A8A0-4E0F7D4B052A

P356

P1433

P1476

Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?

@en

P2093

Dara O Kavanagh

http://www.w3.org/2001/XMLSchema#string

Fadel Bennani

http://www.w3.org/2001/XMLSchema#string

Gillian Chambers

http://www.w3.org/2001/XMLSchema#string

Iqdam Tobbia

http://www.w3.org/2001/XMLSchema#string

Kevin M Barry

http://www.w3.org/2001/XMLSchema#string

Liam O'Grady

http://www.w3.org/2001/XMLSchema#string

Paul W Eustace

http://www.w3.org/2001/XMLSchema#string

Ronan P Waldron

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

The ErbB signaling network: receptor heterodimerization in development and cancer

HER 2/neu protein expression in colorectal cancer

The HER-2/neu oncogene in tumors of the gastrointestinal tract.

Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer.

HER-2/neu evaluation in breast cancer are we there yet?

c-erbB-2 is not a major factor in the development of colorectal cancer

P2888

P304

1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-9-1

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23715688

http://www.w3.org/2001/XMLSchema#string

P6179

1009592729

http://www.w3.org/2001/XMLSchema#string

P698

19118499

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

2648993

http://www.w3.org/2001/XMLSchema#string